Epilepsy is a complex neurological disorder characterized by recurrent seizures that can significantly impact a person’s daily life and well-being. Diagnosing and managing epilepsy requires specialized knowledge, as seizures vary widely in type and severity. Neuroepilepsy experts are neurologists with advanced training focused on this disorder. They use detailed patient histories, advanced EEG monitoring, and neuroimaging techniques to pinpoint the type of epilepsy and identify its underlying causes. This thorough approach enables them to tailor treatments that may include medication, dietary therapies, or surgical options to help control seizures and improve quality of life.
Neuroepilepsy experts play a crucial role in managing patients whose seizures are difficult to control with standard treatments. These specialists often work within multidisciplinary teams, collaborating with neurosurgeons, neuropsychologists, and rehabilitation therapists to provide comprehensive care. Innovations in diagnostics and therapies, such as responsive neurostimulation and precision medicine, have expanded their ability to help patients achieve better seizure control. Beyond clinical care, neuroepilepsy experts also contribute to research, advancing understanding of epilepsy and developing new treatment strategies. Their expertise is vital in supporting patients and families affected by epilepsy, offering hope through improved management and the pursuit of seizure freedom. Ongoing education and advocacy by these specialists continue to reduce stigma and improve resources for those living with epilepsy.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States